In vitro diagnostic medical devices
for bacteriology, mycology, parasitology, reagents for hygiene and related benefits: isolation, identification, serotyping, antibiogram or antifungigram
Further, the MEDDEV only is to be considered for in vitro diagnostic medical devices
for professional users.
Supply of in vitro diagnostic medical devices
, delivery and associated services for the study of histocompatibility: molecular biology reagents, intended for all public assistance establishments - paris hospitals.
Medical devices are currently regulated under three main Directives covering respectively active implantable medical devices (AIMD), medical devices (MDD) and in vitro diagnostic medical devices
Supply, delivery of in vitro diagnostic medical devices
of molecular biology kits captive or not for apparatus for bacteriology and virology for all establishments of assistance publique - hpitaux de paris.
Contract notice: provision of in vitro diagnostic medical devices
for the study of infectious diseases in molecular biology for parasitology and mycology reference number: ao_19-19c
Contract notice: delivery of in vitro diagnostic medical devices
for the needs of "fifth hospital - sofia" ead
"delivery of in vitro diagnostic medical devices
(diagnostic consumables and reagents for laboratory apparatus) for: clinical laboratory, microbiological laboratory, laboratory for transfusion hematology and clinical pathology" for the needs of fifth hospital - sofia ead.
"In April 2017 the EU Commission formally adopted two new regulations on medical devices and in vitro diagnostic medical devices
. One of the main regulatory updates is the implementation of a Unique Device Identification system (UDI) that provides a globally harmonized and consistent approach for the marking and identification of medical devices", comments Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA.
: Provision of "in vitro diagnostic medical devices
not related to apparatus for bacteriology, Mycology, Hygiene reagents (isolation, Identification, Serotyping, Susceptibility testing or antifungograms) and associated services" for all the public assistance - hospitals of paris.
In addition, a new system for risk classification in line with international guidelines will apply to in vitro diagnostic medical devices
"The new EU rules have a twofold aim: making sure that medical devices and in vitro diagnostic medical devices
are safe, while allowing patients to benefit from innovative health care solutions in a timely manner.